111 related articles for article (PubMed ID: 24056966)
1. A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop.
Fernández S; Genis L; Torres-Alemán I
Oncogene; 2014 Aug; 33(32):4114-22. PubMed ID: 24056966
[TBL] [Abstract][Full Text] [Related]
2. Modulation by insulin-like growth factor I of the phosphatase PTEN in astrocytes.
Fernández S; García-García M; Torres-Alemán I
Biochim Biophys Acta; 2008 May; 1783(5):803-12. PubMed ID: 18062928
[TBL] [Abstract][Full Text] [Related]
3. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
4. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
[TBL] [Abstract][Full Text] [Related]
5. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
[TBL] [Abstract][Full Text] [Related]
6. The PTEN/Akt pathway dictates the direct alphaVbeta3-dependent growth-inhibitory action of an active fragment of tumstatin in glioma cells in vitro and in vivo.
Kawaguchi T; Yamashita Y; Kanamori M; Endersby R; Bankiewicz KS; Baker SJ; Bergers G; Pieper RO
Cancer Res; 2006 Dec; 66(23):11331-40. PubMed ID: 17145879
[TBL] [Abstract][Full Text] [Related]
7. Insulin attenuates the insulin-like growth factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN.
Iwase A; Goto M; Harata T; Takigawa S; Nakahara T; Suzuki K; Manabe S; Kikkawa F
J Clin Endocrinol Metab; 2009 Jun; 94(6):2184-91. PubMed ID: 19318457
[TBL] [Abstract][Full Text] [Related]
8. 17betaE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFkappaB-dependent pathway.
Zhang H; Zhao X; Liu S; Li J; Wen Z; Li M
Mol Cell Endocrinol; 2010 Apr; 317(1-2):31-43. PubMed ID: 19932734
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells.
Otaegi G; Yusta-Boyo MJ; Vergaño-Vera E; Méndez-Gómez HR; Carrera AC; Abad JL; González M; de la Rosa EJ; Vicario-Abejón C; de Pablo F
J Cell Sci; 2006 Jul; 119(Pt 13):2739-48. PubMed ID: 16787946
[TBL] [Abstract][Full Text] [Related]
10. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
11. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin inhibits tumor cell growth by suppressing PI3K/Akt signaling via β-catenin-Egr1-mediated PTEN expression.
Lau MT; Klausen C; Leung PC
Oncogene; 2011 Jun; 30(24):2753-66. PubMed ID: 21297666
[TBL] [Abstract][Full Text] [Related]
13. Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model.
Endersby R; Zhu X; Hay N; Ellison DW; Baker SJ
Cancer Res; 2011 Jun; 71(12):4106-16. PubMed ID: 21507933
[TBL] [Abstract][Full Text] [Related]
14. PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2.
Levitt RJ; Georgescu MM; Pollak M
Biochem Biophys Res Commun; 2005 Nov; 336(4):1056-61. PubMed ID: 16154532
[TBL] [Abstract][Full Text] [Related]
15. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways.
Feng Z; Hu W; de Stanchina E; Teresky AK; Jin S; Lowe S; Levine AJ
Cancer Res; 2007 Apr; 67(7):3043-53. PubMed ID: 17409411
[TBL] [Abstract][Full Text] [Related]
16. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
17. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
Tang LL; Yokoyama Y; Wan X; Iwagaki S; Niwa K; Tamaya T
Oncol Rep; 2006 Apr; 15(4):855-9. PubMed ID: 16525671
[TBL] [Abstract][Full Text] [Related]
18. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
19. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the glioma-associated antigen ARF4L after loss of the tumor suppressor PTEN. Laboratory investigation.
Chi JH; Panner A; Cachola K; Crane CA; Murray J; Pieper RO; James CD; Parsa AT
J Neurosurg; 2008 Feb; 108(2):299-303. PubMed ID: 18240926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
